{"organizations": [], "uuid": "b22c001756e0fbae8576a5af4bb46dec892aa7d2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180426.html", "section_title": "Archive News &amp; Video for Thursday, 26 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-reprocell-buys-983-pct-stake-in-bi/brief-reprocell-buys-98-3-pct-stake-in-bioserve-biotechnologies-india-for-1-96-mln-idUSL3N1S3397", "country": "US", "domain_rank": 408, "title": "ReproCell buys 98.3 pct stake in Bioserve Biotechnologies India for $1.96 mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.052, "site_type": "news", "published": "2018-04-26T14:25:00.000+03:00", "replies_count": 0, "uuid": "b22c001756e0fbae8576a5af4bb46dec892aa7d2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-reprocell-buys-983-pct-stake-in-bi/brief-reprocell-buys-98-3-pct-stake-in-bioserve-biotechnologies-india-for-1-96-mln-idUSL3N1S3397", "ord_in_thread": 0, "title": "ReproCell buys 98.3 pct stake in Bioserve Biotechnologies India for $1.96 mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reprocell", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "bioserve biotechnologies india", "sentiment": "negative"}, {"name": "reprocell inc", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "biotechnologies india pvt. ltd", "sentiment": "none"}, {"name": "cancer genetics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 26 (Reuters) - ReproCell Inc\n* Says it buys 1.3 million shares (98.3 percent stake)of Bioserve Biotechnologies India Pvt. Ltd from Cancer Genetics Inc for $1.96 million(213.2 million yen) in total, on April 26\nSource text in Japanese: goo.gl/RHQAHu\n (Beijing Headline News)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://goo.gl/RHQAHu", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-26T14:25:00.000+03:00", "crawled": "2018-04-27T17:15:21.011+03:00", "highlightTitle": ""}